Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

ABVC ABVC BioPharma Inc

1,10

-0,05 (-4,35%)

04 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Article too big to display. Click here to view on the SEC website

ABVC BioPharma (NASDAQ:ABVC)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more ABVC BioPharma Charts.

ABVC BioPharma (NASDAQ:ABVC)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more ABVC BioPharma Charts.

News ABVC BioPharma Inc

AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share
Donnerstag 18 April 2024 (2 Wochen vor) • GlobeNewswire Inc.

ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M
Mittwoch 17 April 2024 (3 Wochen vor) • GlobeNewswire Inc.

ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Licensing Income of $55M and Royalties of up to $50M
Mittwoch 10 April 2024 (4 Wochen vor) • GlobeNewswire Inc.

ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M
Dienstag 26 März 2024 (1 Monat vor) • GlobeNewswire Inc.

AiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging Stock for Real Estate, Demonstrating the Value of ABVC's 23M AiBtl Share Ownership as Hundred Million Dollars
Donnerstag 21 März 2024 (1 Monat vor) • GlobeNewswire Inc.

ABVC BioPharma, Inc. CEO Selected as 2024 Top 10 CEO in CEO Insights Asia Magazine
Dienstag 19 März 2024 (2 Monate vor) • GlobeNewswire Inc.

ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update
Donnerstag 14 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 8-K/A - Current report: [Amend]
Donnerstag 29 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K/A - Current report: [Amend]
Donnerstag 29 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

ABVC's New Horizon for Oncology and Hematology Aims at Cancer Market of Several Hundred Billion Dollars
Dienstag 27 Februar 2024 (2 Monate vor) • GlobeNewswire Inc.

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Freitag 16 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

ABVC BioPharma Executes a Definitive Agreement to Receive License Fees of $3M and Royalties of 2% on Future Revenues
Donnerstag 15 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

Weitere ABVC BioPharma Inc News-Artikel

JP Morgan Chase

Financial Select Sector

Euro vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen